Mammographic screening and "overdiagnosis"

Radiology

Volumn 260, Issue 3, 2011, Pages 616-620

  Kopans, Daniel B ^a   Smith, Robert A ^b   Duffy, Stephen W ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b AMERICAN CANCER SOCIETY   (United States)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

AUTOPSY; BREAST CANCER; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INCIDENCE; CANCER MORTALITY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SCREENING; DIAGNOSTIC ERROR; HUMAN; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; MASTECTOMY; NOTE; OVERDIAGNOSIS; PRIORITY JOURNAL;

BREAST NEOPLASMS; FALSE POSITIVE REACTIONS; FEMALE; HEALTH SERVICES MISUSE; HUMANS; MAMMOGRAPHY; MASS SCREENING; SURVIVAL ANALYSIS; SURVIVAL RATE; UNITED STATES;

EID: 84860389942     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.11110716     Document Type: Note

References (42)

1. Kopans D.B. Beyond randomized controlled trials: Organized mammographic screening substantially reduces breast carcinoma mortality. Cancer 2002;94(2):580-581; author reply 581-583.
2. Altekruse S., Kosary C., Krapcho M., et al. SEER Cancer Statistics Review, 1975-2007. Bethesda, MD: National Cancer Institute, 2010.
3. Jemal A., Ward E., Thun M. Declining death rates reflect progress against cancer. PLoS ONE 2010;5(3):e9584.
4. Berry D.A., Cronin K.A., Plevritis S.K., et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005;353(17):1784-1792. (Pubitemid 41549890)
5. Duffy S.W., Tabár L., Chen H.H., et al. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer 2002;95(3):458-469. (Pubitemid 34810170)
6. Swedish Organised Service Screening Evaluation Group. Reduction in breast cancer mortality from organized service screening with mammography. I. Further confirmation with extended data. Cancer Epidemiol Biomarkers Prev 2006;15(1):45-51.
7. Tabár L., Vitak B., Chen H.H., Yen M.F., Duffy S.W., Smith R.A. Beyond randomized controlled trials: Organized mammographic screening substantially reduces breast carcinoma mortality. Cancer 2001;91(9):1724-1731. (Pubitemid 32377958)
8. Hellquist B.N., Duffy S.W., Abdsaleh S., et al. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: Evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort. Cancer 2011;117(4):714-722.
9. Otto S.J., Fracheboud J., Looman C.W., et al. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: A systematic review. Lancet 2003;361(9367):1411-1417. (Pubitemid 36515040)
10. Esserman L., Shieh Y., Thompson I. Rethinking screening for breast cancer and prostate cancer. JAMA 2009;302(15):1685-1692.
11. Gøtzsche P.C., Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2011(1):CD001877.
12. Welch H.G., Black W.C. Overdiagnosis in cancer. J Natl Cancer Inst 2010;102(9):605-613.
13. Jørgensen K.J., Gøtzsche P.C. Overdiagnosis in publicly organised mammography screening programmes: Systematic review of incidence trends. BMJ 2009;339:b2587.
14. Zahl P.H., Maehlen J., Welch H.G. The natural history of invasive breast cancers detected by screening mammography. Arch Intern Med 2008;168(21):2311- 2316.
15. Kopans D.B., Monsees B., Feig S.A. Screening for cancer: When is it valid? - Lessons from the mammography experience. Radiology 2003;229(2):319-327. (Pubitemid 37310813)
16. Smith R.A., Duffy S., Tabar L. Screening and early detection. In: Barbiera GV, Esteva FJ, Skoracki R, eds. Advanced therapy of breast disease. 3rd ed. Shelton, Conn: People's Medical Publishing House, 2011.
17. Humphrey L.L., Helfand M., Chan B.K., Woolf S.H. Breast cancer screening: A summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137 (5 Part 1):347-360. (Pubitemid 34977137)
18. Welch H.G., Black W.C. Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast: How much more breast cancer can we find? Ann Intern Med 1997;127(11):1023-1028. (Pubitemid 27516615)
19. Duffy S.W., Agbaje O., Tabar L., et al. Overdiagnosis and overtreatment of breast cancer: Estimates of overdiagnosis from two trials of mammographic screening for breast cancer. Breast Cancer Res 2005;7(6):258-265. (Pubitemid 41830164)
20. Dussan C., Zubor P., Fernandez M., Yabar A., Szunyogh N., Visnovsky J. Spontaneous regression of a breast carcinoma: A case report. Gynecol Obstet Invest 2008;65(3):206-211. (Pubitemid 351562924)
21. Cole W.H., Everson T.C. Spontaneous regression of cancer: Preliminary report. Ann Surg 1956;144(3):366-383.
22. Krutchik A.N., Buzdar A.U., Blumenschein G.R., Lukeman J.M. Spontaneous regression of breast carcinoma. Arch Intern Med 1978; 138(11):1734-1735. (Pubitemid 10241152)
23. Lewison E.F. Spontaneous regression of breast cancer. Natl Cancer Inst Monogr 1976;44 : 23-26. (Pubitemid 8036450)
24. Adesunkanmi A.R., Lawal O.O., Adelusola K.A., Durosimi M.A. The severity, outcome and challenges of breast cancer in Nigeria. Breast 2006;15(3):399-409. (Pubitemid 43812214)
25. Von Euler-Chelpin M., Njor S., Lynge E Answer to Jørgensen & Gøtzsche BMJ [serial online] 2009. http://www.bmj.com.proxy.library. emory.edu/content/339/bmj.b2587.full/reply#bmj-el-217871. Accessed March 22, 2011.
26. Johnson A., Shekhdar J. Breast cancer incidence: What do the figures mean? J Eval Clin Pract 2005;11(1):27-31. (Pubitemid 40204137)
27. Duffy S.W., Tabar L., Olsen A.H., et al. Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen 2010; 17(1):25-30.
28. McCann J., Treasure P., Duffy S. Modelling the impact of detecting and treating ductal carcinoma in situ in a breast screening programme . J Med Screen 2004;11(3):117-125. (Pubitemid 39274092)
29. Lawrence G., O'Sullivan E., Kearins O., Tappenden N., Martin K., Wallis M. Screening histories of invasive breast cancers diagnosed 1989-2006 in the West Midlands, UK: Variation with time and impact on 10-year survival. J Med Screen 2009;16(4):186-192.
30. Zackrisson S., Andersson I., Janzon L., Manjer J., Garne J.P. Rate of over-diagnosis of breast cancer 15 years after end of Malmömammographic screening trial: Follow-up study. BMJ 2006;332(7543):689-692.
31. Zahl P.H., Strand B.H., Maehlen J. Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: Prospective cohort study. BMJ 2004; 328(7445):921-924. (Pubitemid 38496981)
32. Olsen A.H., Agbaje O.F., Myles J.P., Lynge E., Duffy S.W. Overdiagnosis, sojourn time, and sensitivity in the Copenhagen mammography screening program. Breast J 2006; 12(4):338-342. (Pubitemid 43989978)
33. Puliti D., Zappa M., Miccinesi G., Falini P., Crocetti E., Paci E. An estimate of overdiagnosis 15 years after the start of mammographic screening in Florence. Eur J Cancer 2009;45(18):3166-3171.
34. Allegra C.J., Aberle D.R., Ganschow P., et al. National Institutes of Health State-of-the- Science Conference statement: Diagnosis and management of ductal carcinoma in situ September 22-24, 2009. J Natl Cancer Inst 2010;102(3):161-169.
35. Page D.L., Dupont W.D., Rogers L.W., Landenberger M. Intraductal carcinoma of the breast: Follow-up after biopsy only. Cancer 1982;49(4):751-758. (Pubitemid 12165434)
36. Yen M.F., Tabár L., Vitak B., Smith R.A., Chen H.H., Duffy S.W. Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening. Eur J Cancer 2003;39(12):1746-1754. (Pubitemid 36897612)
37. Duffy S.W., Tabar L., Vitak B., et al. The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease. Eur J Cancer 2003;39(12):1755-1760. (Pubitemid 36897613)
38. Fisher E.R., Dignam J., Tan-Chiu E., et al. Pathologic findings from the National Surgical Adjuvant Breast Project(NSABP) eightyear update of Protocol B-17: Intraductal carcinoma. Cancer 1999;86(3):429-438. (Pubitemid 29347405)
39. Cuzick J., Sestak I., Pinder S.E., et al. Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: Long-term results from the UK/ANZ DCIS trial. Lancet Oncol 2011;12(1):21-29.
40. Ravdin P.M., Cronin K.A., Howlader N., et al. The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 2007;356(16):1670-1674. (Pubitemid 46631679)
41. Jemal A., Ward E., Thun M.J. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res 2007;9(3):R28.
42. Osborne C.K. Tamoxifen in the treatment of breast cancer. N Engl J Med 1998;339(22):1609-1618. (Pubitemid 28536137)